Published in Circulation on September 14, 2004
D-transposition of the great arteries: the current era of the arterial switch operation. J Am Coll Cardiol (2014) 1.16
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions. Can J Cardiol (2010) 1.00
Postoperative pulmonary and aortic 3D haemodynamics in patients after repair of transposition of the great arteries. Eur Radiol (2013) 0.92
Follow-up outcomes 10 years after arterial switch operation for transposition of the great arteries: comparison of cardiological health status and health-related quality of life to those of the a normal reference population. Eur J Pediatr (2007) 0.89
Midterm results after arterial switch operation for transposition of the great arteries: a single centre experience. J Cardiothorac Surg (2012) 0.86
Aortopathy in Congenital Heart Disease in Adults: Aortic Dilatation with Decreased Aortic Elasticity that Impacts Negatively on Left Ventricular Function. Korean Circ J (2013) 0.80
Aortic dilation in pediatric patients. Eur J Pediatr (2015) 0.77
Dimensions of the ascending aorta in conotruncal heart defects. Pediatr Cardiol (2014) 0.76
Molecular and Genetic Insights into Thoracic Aortic Dilation in Conotruncal Heart Defects. Front Cardiovasc Med (2016) 0.75
Watching the right ventricle in treated congenital heart disease. Heart (2007) 0.75
Aortopathy associated with congenital heart disease: A current literature review. Ann Pediatr Cardiol (2015) 0.75
Cardiac magnetic resonance in adults with congenital heart disease. Methodist Debakey Cardiovasc J (2013) 0.75
Numerical simulation of closure performance for neo-aortic valve for arterial switch operation. Biomed Eng Online (2016) 0.75
Surgery for transposition of great arteries: A historical perspective. Ann Pediatr Cardiol (2015) 0.75
Great vessel root and artery dimensions in transposition of the great arteries repaired with atrial switch operation. Pediatr Cardiol (2013) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg (2002) 6.92
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med (2007) 6.22
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol (1985) (2004) 5.29
Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med (2014) 5.11
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58
Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36
Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr (2010) 3.96
Improvement in congenital heart surgery in a developing country: the Guatemalan experience. Circulation (2007) 3.83
Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr (2004) 3.55
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med (2004) 3.50
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med (2010) 3.42
The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med (2003) 3.28
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol (2008) 2.91
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol (2005) 2.85
Center-specific differences in mortality: preliminary analyses using the Risk Adjustment in Congenital Heart Surgery (RACHS-1) method. J Thorac Cardiovasc Surg (2002) 2.83
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet (2013) 2.82
Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation (2007) 2.76
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol (2004) 2.68
Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol (2004) 2.57
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation (2006) 2.35
A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol (2008) 2.30
Accuracy of guideline recommendations for two-dimensional quantification of the right ventricle by echocardiography. Int J Cardiovasc Imaging (2008) 2.26
Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation (2009) 2.26
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations. Ann Thorac Surg (2012) 2.22
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg (2009) 2.17
Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv (2010) 2.15
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J (2007) 2.14
Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young (2008) 2.10
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
A novel method of expressing left ventricular mass relative to body size in children. Circulation (2008) 2.02
Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol (2010) 2.02
Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors? Pediatrics (2007) 2.00
Complications and risk factors for mortality during congenital heart surgery admissions. Ann Thorac Surg (2007) 1.98
Characteristics of children hospitalized with infective endocarditis. Circulation (2009) 1.97
Factors associated with increased resource utilization for congenital heart disease. Pediatrics (2005) 1.96
Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart (2013) 1.95
The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics (2006) 1.95
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Aortico-left ventricular tunnel: 35-year experience. J Am Coll Cardiol (2004) 1.93
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol (2004) 1.89
Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics (2005) 1.87
Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging (2008) 1.84
The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy. Cardiol Young (2007) 1.83
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol (2010) 1.83
Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet (2002) 1.83
Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol (2008) 1.83
Identification of pressure passive cerebral perfusion and its mediators after infant cardiac surgery. Pediatr Res (2004) 1.82
Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. J Pediatr (2002) 1.80
Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol (2002) 1.78
Report of the 2010 society of thoracic surgeons congenital heart surgery practice and manpower survey. Ann Thorac Surg (2011) 1.76
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation (2006) 1.75
Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J (2006) 1.74
The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg (2003) 1.69
Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg (2008) 1.69
Vascular health in Kawasaki disease. J Am Coll Cardiol (2013) 1.67
Accuracy of echocardiography in low birth weight infants with congenital heart disease. Pediatrics (2005) 1.65
Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr (2010) 1.62
Cardiac and clinical phenotype in Barth syndrome. Pediatrics (2006) 1.61
Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology (2004) 1.61
Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr (2004) 1.60
Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60
Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv (2013) 1.59
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics (2006) 1.59
Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58
Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol (2006) 1.56
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg (2008) 1.56
Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg (2005) 1.55
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med (2012) 1.53
Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation (2004) 1.52
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50
Congenital heart surgery databases around the world: do we need a global database? Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.50
Device closure rates of simple atrial septal defects optimized by the STARFlex device. J Am Coll Cardiol (2006) 1.47
Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J Heart Lung Transplant (2013) 1.47
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg (2012) 1.46
Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg (2005) 1.45
Public reporting of healthcare data: a new frontier in quality improvement. Bull Am Coll Surg (2012) 1.45
Diagnostic errors in pediatric echocardiography: development of taxonomy and identification of risk factors. Circulation (2008) 1.45
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol (2009) 1.45